News for Kiadis Pharma N.V. (KIADF)

Published at

Aug 17, 2023 10:31 AM

by globenewswire.com

mixed

mixed

Allogenic Stem Cell Market Size Worth USD 1.6 billion by 2031, Anticipated to Register a 6.3% CAGR: TMR Study

Increase in the prevalence of chronic diseases, advances in stem cell research, and growth in investment in regenerative medicine are prominent factors...

TKPHF TAKP34.SA TAKN.MX TAK PSTI.TA PSTI ORTX LCTX.TA LCTX CELU 4502.T 4502.S 0A87.L NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA MSB.AX MGTA MESO MEOBF KIADF KDS.AS GMDA FATE CYYNF CYP.AX 4552.T 0RBP.L 0K9E.L

Read more →
Published at

Jun 21, 2022 7:34 AM

by etfdailynews.com

positive

positive

Kiadis Pharma (OTCMKTS:KIADF) Shares Down 2.1%

Read Kiadis Pharma (OTCMKTS:KIADF) Shares Down 2.1% at ETF Daily News

KIADF KDS.AS 0RBP.L

Read more →
Published at

Jul 27, 2021 9:00 AM

by prnewswire.com

positive

positive

SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer

/PRNewswire/ -- SynOx Therapeutics Limited ("SynOx" or the "Company"), the late-stage clinical biopharmaceutical company developing emactuzumab for the...

MRUS KIADF KDS.AS JNJ ETX.L EBS DJNJ3.BA DJNJ2.BA AZN AMGN 0RBP.L 0IGA.L

Read more →
Published at

Jun 8, 2021 12:35 PM

by marketscreener.com

mixed

mixed

Centogene N : CONVENING NOTICE (Form 6-K)

CONVENING NOTICE This is the convening notice for the annual general meeting of shareholders of Centogene N.V. to be held on June 24, 2021 at 3:00pm CEST at Sheraton Amsterdam... | June 8, 2021

SIOX KIADF KDS.AS CNTG 0RBP.L WATC34.SA WAT.MX WAT BMRN ACER 0LTI.L 0HNC.L

Read more →
Published at

Feb 12, 2021 12:01 PM

by benzinga.com

neutral

neutral

Sanofi Offers Cash Buyout For Kiadis

Sanofi SA (NASDAQ: SNY) has launched a takeover offer for Kiadis Pharma NV (OTC: KIADF) to represent an aggregate adjusted ...

SNYNF SNY SNW2.SG SNW2.MU SNW2.F SNW2.BE SNW.SG SNW.MU SNW.F SNW.DE SNW.BE SANF.MI SAN.PA KIADF KDS.AS K3P.SG K3P.F K3P.BE

Read more →

News for Kiadis Pharma N.V. (KIADF)

Allogenic Stem Cell Market Size Worth USD 1.6 billion by 2031, Anticipated to Register a 6.3% CAGR: TMR Study

Kiadis Pharma (OTCMKTS:KIADF) Shares Down 2.1%

SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer

Centogene N : CONVENING NOTICE (Form 6-K)

Sanofi Offers Cash Buyout For Kiadis